Trial intelligence / Profile preview

Comparison of corticosteroid dosages in ultrasound-guided capsular hydrodilatation for adhesive capsulitis

TCTR20201125003Phase 4Completed

Sponsor
Lerdsin Hospital
Start
Jan 2021
Countries
1
01

Overview

Phase 4, randomised, triple-blind trial in adhesive capsulitis (AC) (2 arms), sponsored by Lerdsin Hospital. Primary endpoint: Primary effectiveness endpoint. Started Jan 2021; status: completed.

02

Conditions

adhesive capsulitis (AC)

Beyond the preview

Go deeper on TCTR20201125003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20201125003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call